Literature DB >> 29608961

Genetic diversity analysis of Blastocystis subtypes from both symptomatic and asymptomatic subjects using a barcoding region from the 18S rRNA gene.

Tahereh Rezaei Riabi1, Hamed Mirjalali2, Ali Haghighi3, Mohammad Rostami Nejad4, Mohammad Amin Pourhoseingholi5, Philippe Poirier6, Frederic Delbac7, Ivan Wawrzyniak7, Mohammad Reza Zali5.   

Abstract

Blastocystis is the most prevalent protozoa found in human stool samples. This study aimed to evaluate genetic diversity among Blastocystis subtypes isolated from both symptomatic and asymptomatic subjects as well as the potential correlation between subtypes and symptoms. A total of 55 Blastocystis-positive isolates were included in this study. A barcoding region of the small subunit rDNA was amplified and genetically assessed using MEGA6 and DnaSP regarding the presence of symptoms. BLAST analyses revealed the presence of 5 different subtypes (ST1, ST2, ST3, ST6 and ST7) among the samples. ST3 was the most prevalent subtype (25/55, 45%) while only one ST7 isolate was detected. Moreover, alleles 4 and 86 for ST1; alleles 9, 11 and 12 for ST2; alleles 31, 34, 36, 37 and 52 for ST3; allele 122 for ST6 and allele 137 for ST7 were detected. No statistically significant association was found between gender and symptoms with certain subtypes. Analysis of the intra-subtype variability in both symptomatic and asymptomatic subjects revealed highest similarity among ST1 isolates while lowest similarity was seen among ST3 isolates. Neutrality indices, Tajima's D and Fu's Fs, were negative but only statistically significant for ST3. Furthermore, highest values of Hd, π and S were observed among ST1, ST2 and ST3 isolated from symptomatic patients indicating high level of diversity among isolates obtained from these subjects. In addition, inter-subtype analysis showed the highest similarity between ST1 and ST2 isolates and the lowest similarity between ST2 and ST7 isolates. This is the first study revealing the presence of both ST6 and ST7 isolates in human from Iran. Phylogenetic analysis did not suggest any significant correlation between clinical manifestations and certain subtypes although genetic analysis showed highest value of diversity and significant neutrality indices among ST3 isolates obtained from symptomatic patients.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allele discrimination; Barcoding region; Blastocystis; Clinical manifestations; Genetic variability; Iran

Mesh:

Substances:

Year:  2018        PMID: 29608961     DOI: 10.1016/j.meegid.2018.03.026

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  15 in total

1.  Development and evaluation of high-resolution melting curve analysis for rapid detection and subtyping of Blastocystis and comparison the results with sequencing.

Authors:  Hanieh Mohammad Rahimi; Hamed Mirjalali; Maryam Niyyati; Ali Haghighi; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Parasitol Res       Date:  2019-11-05       Impact factor: 2.289

2.  Molecular characterization and identification of Blastocystis and its subtypes from raccoon (Procyon lotor) in north of Iran.

Authors:  Hanieh Mohammad Rahimi; Sara Nemati; Hamed Mirjalali; Meysam Sharifdini; Mohammad Reza Zali
Journal:  Parasitol Res       Date:  2020-06-24       Impact factor: 2.289

3.  High occurrence of Blastocystis sp. subtype 3 in individuals referred to medical laboratories in Kermanshah, Iran.

Authors:  Bahman Maleki; Javid Sadraei; Abdolhossein Dalimi Asl; Majid Pirestani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022

4.  Association between Blastocystis and body mass index in healthy subjects; a theoretical pilot study.

Authors:  Hamed Mirjalali; Asal Latifi; Ali Taghipour; Abbas Yadegar; Behzad Hatami; Amir Sadeghi; Mohammad Javad Ehsani; Mohammad Reza Zali
Journal:  J Diabetes Metab Disord       Date:  2020-01-03

5.  zzm321990 Blastocystis sp. Prevalence and Subtypes Distribution amongst Syrian Refugee Communities Living in North Lebanon.

Authors:  Salma Khaled; Nausicaa Gantois; Aisha Ayoubi; Gaël Even; Manasi Sawant; Jinane El Houmayraa; Mathieu Nabot; Sadia Benamrouz-Vanneste; Magali Chabé; Gabriela Certad; Dima El Safadi; Fouad Dabboussi; Monzer Hamze; Eric Viscogliosi
Journal:  Microorganisms       Date:  2021-01-16

6.  Investigation of neglected protists Blastocystis sp. and Dientamoeba fragilis in immunocompetent and immunodeficient diarrheal patients using both conventional and molecular methods.

Authors:  Fakhriddin Sarzhanov; Funda Dogruman-Al; Monica Santin; Jenny G Maloney; Ayse Semra Gureser; Djursun Karasartova; Aysegul Taylan-Ozkan
Journal:  PLoS Negl Trop Dis       Date:  2021-10-06

7.  Association of Blastocystis ST6 with higher protease activity among symptomatic subjects.

Authors:  Seyed Ahmad Karamati; Hamed Mirjalali; Maryam Niyyati; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Ali Haghighi; Seyyed Javad Seyyed Tabaei
Journal:  BMC Microbiol       Date:  2021-10-19       Impact factor: 3.605

8.  Comprehensive Study of Phenotypic and Growth Rate Features of Blastocystis Subtypes 1-3 and 6 in Symptomatic and Asymptomatic Subjects.

Authors:  Seyed Ahmad Karamati; Hamed Mirjalali; Maryam Niyyati; Tahereh Rezaei Riabi; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Ali Haghighi; Seyyed Javad Seyyed Tabaei; Mohammad Reza Zali
Journal:  Iran J Parasitol       Date:  2019 Apr-Jun       Impact factor: 1.012

9.  Molecular Detection and Subtyping of Blastocystis in Korean Pigs.

Authors:  Seunghyun Paik; Byeong Yeal Jung; Haeseung Lee; Mi-Hye Hwang; Jee Eun Han; Man Hee Rhee; Tae-Hwan Kim; Oh-Deog Kwon; Dongmi Kwak
Journal:  Korean J Parasitol       Date:  2019-10-31       Impact factor: 1.341

10.  A Study on the Prevalence and Subtype Diversity of the Intestinal Protist Blastocystis sp. in a Gut-Healthy Human Population in the Czech Republic.

Authors:  Zuzana Lhotská; Milan Jirků; Oldřiška Hložková; Kristýna Brožová; Dagmar Jirsová; Christen Rune Stensvold; Martin Kolísko; Kateřina Jirků Pomajbíková
Journal:  Front Cell Infect Microbiol       Date:  2020-10-06       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.